Pappas Capital — 2015 Investments

3 investments dated 2015 · listed companies and verified rows first · show all

Afferent Pharmaceuticals inJul 2015

BiotechSan Mateo, US

Anthony Ford(Executive Officer)inMichael Kitt(Executive Officer)inKathleen Sereda Glaub(Executive Officer, Director)in

BoardKevin Starr(Director)inArthur Pappas(Director)Liam Ratcliffe(Director)

Co-investorsDomain Associates Fidelity Investments Jennison Associates Third Rock Ventures

Amplyx PharmaceuticalsAug 2015

Developing broad-spectrum antifungal agents for invasive fungal infections.

BiotechSan Diego, US

Mitchell Mutz(Executive Officer, Director)

BoardChrysa Mineo(Director)Jack Florio(Director)Elaine Heron(Director)Santosh Vetticaden(Director)Karen Talmadge(Director)

Co-investorsNew Enterprise Associates (NEA)RiverVest Venture Partners Sofinnova Ventures Sofinnova Venture Partners

CoLucid PharmaceuticalsJan 2015

BiotechDurham, US

Bernice Kuca(Executive Officer)Mathers P. Thomas(Executive Officer, Director)Nadia Rupniak(Executive Officer)Timothy C. Gupton(Executive Officer)

BoardJesse I. Treu(Director)inRichard J. Markham(Director)

Co-investorsDomain Associates TVM Capital TVM Capital Life Science

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.